A J Butwick1, J Bentley2, S A Leonard3, S L Carmichael3, Y Y El-Sayed4, O Stephansson5,6, N Guo1. 1. Department of Anesthesiology, Perioperative, and Pain Medicine, Stanford University School of Medicine, Stanford, CA, USA. 2. Quantitative Sciences Unit, Stanford University, Stanford, CA, USA. 3. Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA. 4. Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, USA. 5. Department of Medicine Solna, Clinical Epidemiology Unit, Stockholm, Sweden. 6. Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Abstract
OBJECTIVE: To assess the relation between maternal body mass index (BMI) and pregnancy-related venous thromboembolism (VTE). DESIGN: Cohort study. SETTING AND POPULATION: A total of 2 449 133 women with singleton pregnancies who underwent delivery hospitalisation in California between 2008 and 2012. METHODS: Association of pre-pregnancy BMI and the risk of an antepartum and postpartum VTE was examined using logistic regression, with normal BMI as reference. MAIN OUTCOME MEASURES: Antepartum and postpartum VTE-related hospitalisation. RESULTS: The prevalence of antepartum and postpartum VTE increased with increasing BMI (antepartum: 2.3, 3.0, 3.8, 4.2, 4.7, and 10.6 per 10 000 women for underweight, normal BMI, overweight, obesity class I, II, and III, respectively, P < 0.001; postpartum: 2.0, 3.1, 3.9, 5.6, 9.0, and 13.2 per 10 000 women, P < 0.01). The adjusted odds of antepartum and postpartum VTE increased progressively with increasing BMI, with obesity class III women having the highest risk of pregnancy-related VTE compared with normal BMI women: adjusted odds ratio for antepartum VTE: 2.9; 95% CI 2.2-3.8 and adjusted odds ratio for postpartum VTE: 3.6; 95% CI 2.9-4.6. CONCLUSIONS: Our findings clearly demonstrate an increasing risk of pregnancy-related VTE with increasing BMI. TWEETABLE ABSTRACT: Obesity was associated with increased odds of antepartum and postpartum venous thromboembolism.
OBJECTIVE: To assess the relation between maternal body mass index (BMI) and pregnancy-related venous thromboembolism (VTE). DESIGN: Cohort study. SETTING AND POPULATION: A total of 2 449 133 women with singleton pregnancies who underwent delivery hospitalisation in California between 2008 and 2012. METHODS: Association of pre-pregnancy BMI and the risk of an antepartum and postpartum VTE was examined using logistic regression, with normal BMI as reference. MAIN OUTCOME MEASURES: Antepartum and postpartum VTE-related hospitalisation. RESULTS: The prevalence of antepartum and postpartum VTE increased with increasing BMI (antepartum: 2.3, 3.0, 3.8, 4.2, 4.7, and 10.6 per 10 000 women for underweight, normal BMI, overweight, obesity class I, II, and III, respectively, P < 0.001; postpartum: 2.0, 3.1, 3.9, 5.6, 9.0, and 13.2 per 10 000 women, P < 0.01). The adjusted odds of antepartum and postpartum VTE increased progressively with increasing BMI, with obesity class III women having the highest risk of pregnancy-related VTE compared with normal BMI women: adjusted odds ratio for antepartum VTE: 2.9; 95% CI 2.2-3.8 and adjusted odds ratio for postpartum VTE: 3.6; 95% CI 2.9-4.6. CONCLUSIONS: Our findings clearly demonstrate an increasing risk of pregnancy-related VTE with increasing BMI. TWEETABLE ABSTRACT: Obesity was associated with increased odds of antepartum and postpartum venous thromboembolism.
Authors: Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik Journal: Chest Date: 2012-02 Impact factor: 9.410
Authors: Julia Ellis-Kahana; Andrew D Sparks; Alexis C Gimovsky; Andra H James; Homa K Ahmadzia Journal: Thromb Res Date: 2020-04-23 Impact factor: 3.944
Authors: Heather A Frey; Robert Ashmead; Alyssa Farmer; Yoshie H Kim; Cynthia Shellhaas; Reena Oza-Frank; Rebecca D Jackson; Maged M Costantine; Courtney D Lynch Journal: JAMA Netw Open Date: 2022-06-01
Authors: Stephanie A Leonard; Barbara Abrams; Elliott K Main; Deirdre J Lyell; Suzan L Carmichael Journal: Am J Clin Nutr Date: 2020-04-01 Impact factor: 7.045